Associate Dir-Marketing(GI/HBC)-OBU New Assets-上海

This role needs to take lead in one tumor area including all assets in this disease area. In addition, this role also needs to be responsible for one pan-cancer molecule across DAs to have overall compound strategy, shapes Target Product Profiles (TPPs), defines segmentation and positioning, co-develop access strategy in China, informs evidence generation, and leads cross-functional alignment, such as global strategy, forecasting team, China R&D, China medical, market access and commercial team, etc. Leading strategy and tactics to bridge existing AZ presence in specific oncology disease area  into future new launchings launches by partnering with cross function team to secure non-regrettable new launches & LCM.

ROLE & RESPONSIBILITIES

• Asset Strategy & TPP Ownership: Co-lead Target Product Profile creation and iteration; define must-have clinical attributes, label aspirations, and commercial positioning.

• Insight Generation: Commission and synthesize primary research with oncologists, pathologists,  diagnosis partners,  payers, and patients; integrate secondary data, RWE, and competitive intelligence into actionable strategic choices. Gather insights from field engagement with KEEs.

• Evidence Strategy Partnership: Inform clinical, medical, and China specific evidence plans (comparators, subgroup analyses, PROs, economic models) to enable guideline inclusion, inform clinical practice guidance, and payer adoption.

• Access & Pricing Readiness: Shape early value story, budget impact and cost-offset hypotheses, and payer evidence needs; develop pre-NDA value communication and pricing scenarios with Market Access.

• Go-to-Market Foundations: Define early brand architecture, naming considerations, brand short-long strategy, business model and omnichannel readiness requirements; plan pre-launch disease education and KOL/advocacy engagement handoffs with medical team together.

• Analytics & Forecasting: Lead epidemiological sizing, uptake curves, and sensitivity analyses; develop assumptions libraries and dashboards to pressure-test commercial potential.

• Global Input & Adaptation: Gather global insights (US, EU, Japan, China, Emerging Markets) to ensure global relevance and local feasibility; provide toolkits for future local planning.

• Compliance & Ethics: Ensure all activities adhere to promotional codes, patient safety, data privacy, and scientific integrity standards.

REQUIREMENTS

• Education: Bachelor’s degree required; MBA or advanced degree in life sciences, epidemiology, health economics, or related field preferred.

• Experience: 10+ years in pharma/biotech commercial or strategy roles, with 10+ years in NPP/Global Marketing/Portfolio Strategy

• Must have experience in oncology/special care new product launch and strategic role.

• Skills:

• Strategic Marketing & NPP: TPP shaping, value proposition design, segmentation, scenario planning.

• Evidence & Access: HEOR fundamentals, endpoint selection, economic modeling inputs, payer evidence needs.

• Analytics: Forecasting, epidemiology, sensitivity analyses, triangulation across data sources.

• Leadership & Influence: Matrix leadership, stakeholder management, KOL engagement, decision facilitation.

• Communication: Clear, concise storytelling that translates complex science into customer-centric value.

Date Posted

02-Mar-2026

Closing Date

26-Mar-2026

AstraZeneca embraces diversity and equality of opportunity.  We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills.  We believe that the more inclusive we are, the better our work will be.  We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics.  We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorization and employment eligibility verification requirements.